Cases 21 - 30 of 69
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED
as 3:2021cv15137
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. MACLEODS PHARMACEUTICALS, LTD. et al
as 1:2021cv02309
Plaintiff:
JANSSEN PHARMACEUTICA NV, JANSSEN RESEARCH AND DEVELOPMENT, LLC and JANSSEN PHARMACEUTICALS, INC.
Defendant:
MACLEODS PHARMA USA, INC. and MACLEODS PHARMACEUTICALS, LTD.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. MACLEODS PHARMACEUTICALS, LTD. et al
as 1:2021cv00697
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
MACLEODS PHARMA USA, INC. and MACLEODS PHARMACEUTICALS, LTD.
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Sun Pharmaceutical Industries Ltd.
as 1:2020cv01479
Plaintiff:
Allergan USA, Inc., Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company and others
Defendant:
Sun Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Hetero Labs Limited et al
as 1:2020cv01344
Plaintiff:
Allergan USA, Inc., Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company and others
Defendant:
Hetero Labs Limited and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 2:2020cv13103
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Counter Claimant:
MYLAN LABORATORIES LIMITED
Defendant:
MYLAN PHARAMACEUTICALS, INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 3:2020cv13103
Plaintiff:
JANSSEN RESEARCH & DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV and JANSSEN PHARMACEUTICALS, INC.
Defendant:
MYLAN INSTITUTIONAL LLC, MYLAN LABORATORIES LIMITED and MYLAN PHARAMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC.
as 1:2020cv03102
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA INC.
as 3:2020cv03106
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
AUROBINDO PHARMA USA INC.
Cause Of Action: 15 U.S.C. § 1126
Janssen Pharmaceuticals, Inc. et al v. Pharmascience Inc. et al
as 1:2019cv02313
Plaintiff:
Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc.
Defendant:
Pharmascience Inc., SpecGx LLC and Mallinckrodt plc
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
